Phase III study of an optimized chemotherapy + Avastin strategy +/- Tarceva in metastatic colorectal cancer.

ABSTRACT: Primary objectives: To show superiority in Progression Free Survival (PFS) from the date of randomization with Avastin plusTarceva compared to Avastin alone.

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2522328 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR